Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (931-940 of 1,350) with videos related to

Pageof 135
Sort By:
Drug Development Research|January 13, 2026
Desmopressin Induces Mitochondrial Fragmentation and Dysfunction in Human U87 MG Glioma Cells via CaMKII-Drp1 Signaling PathwaySitao Liang, Yonghua Zhu, Jiahao Su, et al.
Drug Development Research|January 19, 2026
Targeting of PCSK9 in the Management of Alzheimer's Disease: Expanding the New Potential Key PlayerMansour Alanazi, Hayder M Al-Kuraishy, Nawar R Hussain, et al.
Drug Development Research|January 28, 2026
Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal CancerAbdullah A Alshehri, Wael Y Khawagi
Drug Development Research|February 3, 2026
Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic InnovationMohammad Javad Mehran, Sara Mohammadzadeh, Mansoor Bolideei, et al.
Drug Development Research|February 2, 2026
Halting Tuberculosis in Its Tracks: Advances and Strategies for Discovering Therapeutic Targets in Mycobacterium tuberculosisAyushi Sharma, Gyanendra Singh, Rahul Shrivastava
Drug Development Research|November 23, 2025
Screening Natural Phenolic Compounds for Blood-Brain Barrier Permeability, Alongside GSK-3β, CK-1δ, and AChE Inhibition, for the Treatment of Alzheimer's DiseasePerihan Gürbüz, Şengül Dilem Doğan, Miyase Gözde Gündüz, et al.
Drug Development Research|November 17, 2025
Leveraging the Fragment Merging Approach for Synthetizing Novel Selanyl Phenyl Acetamide Thiazolidinedione Hybrids Endowed With Apoptotic Potential for Cancer TreatmentSaad Shaaban, Ayman Abo Elmaaty, Aya Yaseen Mahmood Alabdali, et al.
Drug Development Research|December 18, 2024
Exosome-Shuttled METTL14 From AML-Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A-IGF2BP3-Dependent MechanismCheng Wang, Rui Song, Jinjin Yuan, et al.
Drug Development Research|February 13, 2025
Unraveling the Curcumin's Molecular Targets and Its Potential in Suppressing Skin Inflammation Using Network Pharmacology and In Vitro StudiesAnjana Sureshbabu, Elena Smirnova, Do Thi Cat Tuong, et al.
Drug Development Research|December 11, 2024
Heme Oxygenase-1 Overexpression Activates the IRF1/DRP1 Signaling Pathway to Promote M2-Type Polarization of Spinal Cord MicrogliaWenping Lin, Ziming Cai, Jinzhu Liang, et al.
Pageof 135

Showing results (931-940 of 1,350) with videos related to

Sort By:
Pageof 135
Drug Development Research|January 13, 2026
Desmopressin Induces Mitochondrial Fragmentation and Dysfunction in Human U87 MG Glioma Cells via CaMKII-Drp1 Signaling PathwaySitao Liang, Yonghua Zhu, Jiahao Su, et al.
Drug Development Research|January 19, 2026
Targeting of PCSK9 in the Management of Alzheimer's Disease: Expanding the New Potential Key PlayerMansour Alanazi, Hayder M Al-Kuraishy, Nawar R Hussain, et al.
Drug Development Research|January 28, 2026
Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal CancerAbdullah A Alshehri, Wael Y Khawagi
Drug Development Research|February 3, 2026
Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic InnovationMohammad Javad Mehran, Sara Mohammadzadeh, Mansoor Bolideei, et al.
Drug Development Research|February 2, 2026
Halting Tuberculosis in Its Tracks: Advances and Strategies for Discovering Therapeutic Targets in Mycobacterium tuberculosisAyushi Sharma, Gyanendra Singh, Rahul Shrivastava
Drug Development Research|November 23, 2025
Screening Natural Phenolic Compounds for Blood-Brain Barrier Permeability, Alongside GSK-3β, CK-1δ, and AChE Inhibition, for the Treatment of Alzheimer's DiseasePerihan Gürbüz, Şengül Dilem Doğan, Miyase Gözde Gündüz, et al.
Drug Development Research|November 17, 2025
Leveraging the Fragment Merging Approach for Synthetizing Novel Selanyl Phenyl Acetamide Thiazolidinedione Hybrids Endowed With Apoptotic Potential for Cancer TreatmentSaad Shaaban, Ayman Abo Elmaaty, Aya Yaseen Mahmood Alabdali, et al.
Drug Development Research|December 18, 2024
Exosome-Shuttled METTL14 From AML-Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A-IGF2BP3-Dependent MechanismCheng Wang, Rui Song, Jinjin Yuan, et al.
Drug Development Research|February 13, 2025
Unraveling the Curcumin's Molecular Targets and Its Potential in Suppressing Skin Inflammation Using Network Pharmacology and In Vitro StudiesAnjana Sureshbabu, Elena Smirnova, Do Thi Cat Tuong, et al.
Drug Development Research|December 11, 2024
Heme Oxygenase-1 Overexpression Activates the IRF1/DRP1 Signaling Pathway to Promote M2-Type Polarization of Spinal Cord MicrogliaWenping Lin, Ziming Cai, Jinzhu Liang, et al.
Pageof 135